Close

Jump to:

  • Navigation
  • Content
  • Footer
BIOHM | Future of Home hero image

BIOHM | Future of Home

Follow

Multi-award-winning leader in nature inspired innovation, revolutionising the built environment

105%
 - 
Funded 5 Aug 2020
£750,001 target
£792,544 from 600 investors
More
Less

Business overview

Location London, United Kingdom
Social media
Website www.biohm.co.uk
Sectors Property Mixed Digital/Non-Digital Mixed B2B/B2C
Company number 10271534
Incorporation date 11 Jul 2016
More
Less

Investment summary

Type Equity
Valuation (pre-money) £9.8M
Equity offered 7.48%
Tax relief

EIS

More
Less

Business highlights

  • World's first community bio-manufacturer of Mycelium insulation
  • Commercialising bio-technologies that consume 'waste' and carbon
  • Developing groundbreaking innovations to end plastic pollution
  • Patented construction system for agile and regenerative buildings
More
Less

Key features

  • Secondary Market
  • Nominee investment min. £17.40 +
  • Idea
  • Team
  • Updates
  • Investors 600
  • Discussion
  • Documents

Idea

Introduction

Biohm is a multi-award-winning bio-technology company that is revolutionising construction through nature-inspired innovation. Placing biological systems at the heart of our inspiration (biomimicry), we harness the philosophies of the Circular Economy to create a step-change in building technologies, materials, and manufacturing methods.

We aim to create a healthy and regenerative built environment through our bio-based materials, circular construction system, Triagomy, and our range of consultation services to industry. By utilising readily available organic and synthetic by-products and ‘waste’ materials from industry we bio-manufacture low-cost, high-performing, and carbon-negative alternatives to unhealthy and environmentally damaging building materials.

We are now scaling our technologies to meet demand and fulfil major projects. However, we realise that we can't revolutionise an entire industry alone. Alongside our leading industrial, academic and public network, we need you!

Substantial accomplishments to date

Our carbon-negative bio-based materials include building insulation made out of mycelium (the root structure of mushrooms) and Orb (Organic Refuse biocompound), a 100% natural sheet material made out of food and agricultural surplus.

They are out-performing leading synthetic and carbon-heavy alternatives and will be combined to form our construction system, Triagomy (patent filed, published or granted in almost 60 countries).

Biohm continues to gather awards & recognition from government, industry and academia. In collaboration with the Onion Collective, we recently won the Waitrose and Partners Plan Plastic Prize: The Million Pound Challenge and a Power to Change grant - totalling almost £600,000 - to further develop our plastic-consuming mycelium strains and build what we believe to be the world’s first community-led bio-manufacturing facility.

Organisations and governments from across Europe, North Africa, the US, and South Asia have extended invitations and offered support for Biohm to set up our revolutionary facilities. We are a member of the internationally recognised Ellen MacArthur Foundation, part of the Unreasonable Group's 2020 cohort. Amongst other shortlists and awards, Biohm has been shortlisted as one of the UN's Young Champions of the Earth.

We have been profiled by internationally recognised print and television news companies that have championed both our passion for innovative materials and our socially, economically and environmentally restorative business model.

Monetisation strategy

Mycelium Insulation | Our first UK facility is scheduled to begin production in Q4 2020 - ramping up to produce up to 9,000 sqm of insulation p/m. With superior performance, price competitiveness and environmental/social impact, we expect our market share to steadily grow.

Orb | We have developed what we understand to be unique 100% natural, biodegradable and renewable binder, allowing us to make sheet materials out of food and agricultural waste that meet increasing demand for healthy and regenerative alternatives in construction.

Carbon Crediting Waste Management | As 'waste' is a primary input for our products we intend to offer waste management services supplementing production costs and offering genuine carbon credits.

Services | We offer a range of design, consultancy and material development services to support the industry's transition.

Construction Systems | As our materials develop over the next 2-3 years, we aim to launch our first of many nature-inspired constructon systems and lead property development projects.

Use of proceeds

Biohm is a thought-leader in the field of bio-technology and all of our product offerings are grounded in advanced research carried out by an inspirational leading team. At a time of climate crisis and economic change, we believe that investing in our most valuable assets will drive our growth and accelerate the delivery of our impact, globally.

Team Growth – 38%

It is critical to ensure that our rapid growth is adequately supported by an outstanding team. As a pioneer in ethical work environments, we believe that the true value of biohm lies in its people.

R&D Scale-up – 22%

As an IP-rich company that has boot-strapped its way into world leadership, we aim to scale-up our R&D capacity to meet demand for our services and continue to innovate.

Intellectual property (IP) – 22%

We plan to protect our ever-evolving IP ethicallly and equitably to maintain our market position.

Product Accreditation and Professional Services – 18%

An essential step to commercialisation.

Open an account to get access to the team members of BIOHM | Future of Home

Sign up

Already have an account? Log in

To comply with financial regulations, we can only show full campaign details to registered users.

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Only shareholders can access this page

If you successfully purchase a share lot of this business, you will be granted access.

Buy shares

Share on:

Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future.

This campaign for BIOHM | Future of Home has been approved by Seedrs Limited (trading as Republic Europe) ("Republic Europe", "us" or "we"), as of 4 June 2020 as a financial promotion. Republic Europe is authorised and regulated by the Financial Conduct Authority with firm reference number 550317. In approving this campaign, Republic Europe has concluded that the information, taken as a whole, is "fair, clear and not misleading." This means that for factual statements we have reviewed evidence of their accuracy, and that for aspirational statements we believe they are phrased appropriately in light of their speculative nature. You should note that in the case of factual statements, the evidence we review is provided by the business, and we do not audit it, which means that we may not be able to identify forged or altered evidence. You should further note that in the case of aspirational statements, the nature of the type of businesses presented on the Republic Europe platform is such that they are likely to have high ambitions, and we may approve statements that convey those ambitions even where we do not believe, or we do not have a view on whether it is likely, that they will be fully realised. The pre-money valuation and investment sought in the campaign are those set by the business: they are not reviewed or established by us, and the valuation is not an independent view of what the business is worth. Given the nature and type of businesses presented on the Republic Europe platform, it is possible that the business has very little cash remaining prior to receiving this investment, and the investment sought may be necessary for the business's on-going existence.

Republic Europe does not make investment recommendations to you. No communications from Republic Europe, through this website or any other medium, should be construed as an investment recommendation. Further, nothing on this website shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Republic Europe does not provide legal, financial or tax advice of any kind. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Republic Europe, you should consult a professional adviser.

Tax Relief (SEIS)

This business is eligible for SEIS relief - providing qualifying investors with income tax relief of 50% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Tax Relief (EIS)

This business is eligible for EIS relief - providing qualifying investors with income tax relief of 30% of their investment and certain other tax reliefs. Tax treatment depends on individual circumstances and is subject to change in future. Click to learn more.

Valuation (pre-money)

Valuation rounded from £9,804,987

This is the fully-diluted pre-money valuation of the business (i.e. before the new investment comes in and including issued options and other equity interests). In contrast, the post-money valuation is based on inclusion of the new investment in the value.

It is calculated as the pre-money valuation plus the amount of new investment. e.g. If Company A is ascribed a pre-money valuation of £1,200,000 by prospective investors investing £300,000, its post-money valuation is £1,500,000.

The investee business is responsible for setting its own valuation, it has not been prescribed by Seedrs.

Pitch type

Investing in a regular equity campaign is the simplest and most common way to invest in a startup. You decide which business you want to invest in, and if the campaign hits its funding target then you will become one of their shareholders. As the company becomes more valuable, so do your shares; allowing you the opportunity to share in the future success of the business.

Learn more about pitch type on Seedrs

Equity Offered

The equity offered is the percentage of the company’s shares being issued in return for the amount of investment raised.

When the amount raised is less than 100%, the equity offered is based on the target raise. Once the company has raised over 100% it is based on the total raised.

In some scenarios, entrepreneurs may accept additional direct investment after closing their Seedrs campaign. Provided this is within 6 months of the closing and on the same terms, we do not typically offer pre-emption rights on that extra investment (where you have the opportunity to invest again to maintain your percentage shareholding).

Learn more about investing and pre-emption rights.

Nominee investment

This shows if you are able to choose, when making an investment, that you be represented by, and your shareholding be managed by, the Nominee investment.

Find out more

Custodian

If you invest in this Campaign, Seedrs will act as Custodian rather than provide our standard nominee service. This is due to the fact that the business is not directly involved in the share sale and Seedrs will not benefit from any rights under a shareholder agreement. As a result, Seedrs will handle administrative tasks as we do normally, but you will not have information or voting rights, updates from the business, preemption on future fundraising, or ongoing support about business trading activity.

Learn more about Custodian here

Secondary market

This shows if the business has opted-in or opted-out of allowing its shares to be bought and sold on the secondary market.

Find out more

Direct investment

This is an option to invest and hold shares 'directly' in the company (rather than via the Nominee investment). This option is only available to those investing over the threshold amount, which is determined by the fundraising company.

If you choose to hold your shares directly, you will be responsible for any contractual or administrative arrangements with the company you are investing in.

Find out more

Payment options

We are not able to accept card payments for investments into this sector. You can pay for your investment by creating a bank transfer, using funds in your investment account or create a Pay by Bank payment. Your investment will only be completed once the funds have reached our account.

Business Involvement

This Campaign offers shares for sale in business that is not directly involved in this Campaign or the sale. As a result, the Campaign and post-investment experience, including investor rights, will differ from a business-led campaign on Seedrs. Most notably, the business will not engage with investors in the discussion forums both during and after the sale or provide any updates to investors.

Learn more here

Payment options

We are not able to accept Pay by Bank payments for investments into this sector. You can pay for your investment with a card payment, by creating a bank transfer or by using funds in your investment account. Your investment will only be completed once the funds have reached our account.

Drawdowns

This campaign offers the ability to pay for an investment by drawdowns.

Security Token

A security token is a digital asset that represents ownership or other rights. It is a digital form of traditional investments. In the future, you may be able to trade your investment through compatible exchanges.

Warning

You are following a link outside of europe.republic.com.

None of the information in constitutes part of the campaign and it has not been approved or reviewed by Seedrs.

ContinueCancel